158 results on '"Volchkov, Pavel"'
Search Results
2. AAV genome modification for efficient AAV production
3. Molecular Basis of Pancreatic Neuroendocrine Tumors.
4. A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases.
5. Genotypic differentiation and evolutionary dynamics of puumala orthohantavirus (PUUV).
6. Alternative Ways to Obtain Human Mesenchymal Stem Cells from Embryonic Stem Cells.
7. Complex Evolutionary Dynamics of H5N8 Influenza A Viruses Revealed by Comprehensive Reassortment Analysis.
8. Culture of human retinal explants as an ex vivo model for retinal gene therapy
9. Codon-optimization in gene therapy: promises, prospects and challenges
10. Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations
11. Novel and Previously Known Mutations of the KCNV2 Gene Cause Various Variants of the Clinical Course of Cone Dystrophy with Supernormal Rod Response in Children.
12. IAVCP (Influenza A Virus Consensus and Phylogeny): Automatic Identification of the Genomic Sequence of the Influenza A Virus from High-Throughput Sequencing Data.
13. Codon-optimization in gene therapy: promises, prospects and challenges.
14. Abundant Intra-Subtype Reassortment Revealed in H13N8 Influenza Viruses.
15. Gene Therapy Approaches for the Treatment of Hemophilia B
16. Generation of two human induced pluripotent stem cell lines (ABi001-A and ABi002-A) from cone dystrophy with supernormal rod response patients caused by KCNV2 mutation
17. Models of Congenital Adrenal Hyperplasia for Gene Therapies Testing
18. Characterizing and Quenching Autofluorescence in Fixed Mouse Adrenal Cortex Tissue
19. Cap-Independent Circular mRNA Translation Efficiency
20. Microbiota regulates type 1 diabetes through Toll-like receptors
21. Establishment of a human induced pluripotent stem cell line (ABi004-A) carrying a compound heterozygous mutation in the KCNV2 gene
22. Robust AAV Genotyping Based on Genetic Distances in Rep Gene That Are Maintained by Ubiquitous Recombination
23. Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
24. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study
25. Boosting of the SARS-CoV-2–Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine
26. Generation of induced pluripotent stem cell line (MIPTi002-A) derived from a patient with a heterozygous type mutation in the CDC73 gene
27. Generation of induced pluripotent stem line (MIPTi001-A) derived from patient with X-linked adrenoleukodystrophy (X-ALD)
28. Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine
29. SARS-CoV-2 specific T cells and antibodies in COVID-19 protection: a prospective study
30. Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas
31. Avian Influenza in Wild Birds and Poultry: Dissemination Pathways, Monitoring Methods, and Virus Ecology
32. Human embryo genome editing: an interdisciplinary approach
33. Innate immunity and intestinal microbiota in the development of Type 1 diabetes
34. 5-year Follow up After MSC-based Treatment of Severe Acute Respiratory Distress Syndrome
35. Gender Bias in Autoimmunity Is Influenced by Microbiota
36. Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
37. Convolutional Neural Networks Can Predict Retinal Differentiation in Retinal Organoids
38. The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination
39. MYB is an Essential Regulator of Primitive Human Hematopoiesis in Pluripotent Stem Cell Differentiation Cultures
40. Successful CRISPR/Cas9 mediated homologous recombination in a chicken cell line
41. Evaluation of the potential defensive strategy against Influenza A in cell line models
42. Evaluation of defense strategy against Influenza A in cell line models
43. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes
44. The safety of human pluripotent stem cells in clinical treatment
45. Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors
46. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
47. A critical role for regulatory T cell–mediated control of inflammation in the absence of commensal microbiota
48. CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs
49. Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes
50. Diverse Epigenetic Profile of Novel Human Embryonic Stem Cell Lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.